Marrone Bio Innovations Inc (MBII) Given Consensus Recommendation of “Buy” by Brokerages

Shares of Marrone Bio Innovations Inc (NASDAQ:MBII) have earned a consensus recommendation of “Buy” from the six analysts that are presently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $2.08.

A number of analysts recently commented on MBII shares. ValuEngine lowered Marrone Bio Innovations from a “sell” rating to a “strong sell” rating in a research note on Thursday, March 1st. Jefferies Financial Group reaffirmed a “hold” rating and set a $1.55 price objective on shares of Marrone Bio Innovations in a research note on Wednesday, March 21st. Zacks Investment Research lowered Marrone Bio Innovations from a “hold” rating to a “sell” rating in a research note on Wednesday, April 11th. BidaskClub lowered Marrone Bio Innovations from a “strong-buy” rating to a “buy” rating in a research note on Thursday, April 12th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $4.00 price objective on shares of Marrone Bio Innovations in a research note on Tuesday, May 15th.

Marrone Bio Innovations opened at $1.72 on Tuesday, MarketBeat.com reports. The company has a current ratio of 2.63, a quick ratio of 1.76 and a debt-to-equity ratio of 1.40. The firm has a market capitalization of $195.00 million, a price-to-earnings ratio of -1.61 and a beta of -0.54. Marrone Bio Innovations has a fifty-two week low of $0.85 and a fifty-two week high of $3.39.

Marrone Bio Innovations (NASDAQ:MBII) last posted its quarterly earnings data on Thursday, May 10th. The basic materials company reported ($0.04) EPS for the quarter, meeting analysts’ consensus estimates of ($0.04). The company had revenue of $4.32 million for the quarter. equities analysts predict that Marrone Bio Innovations will post -0.16 EPS for the current year.

Marrone Bio Innovations Company Profile

Marrone Bio Innovations, Inc provides bio-based pest management and plant health products primarily for agricultural and water markets in the United States and internationally. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation.

Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply